GB1184023A - Process for the production of Substituted Tetrahydro-1,4-Oxazines - Google Patents

Process for the production of Substituted Tetrahydro-1,4-Oxazines

Info

Publication number
GB1184023A
GB1184023A GB1219168A GB1219168A GB1184023A GB 1184023 A GB1184023 A GB 1184023A GB 1219168 A GB1219168 A GB 1219168A GB 1219168 A GB1219168 A GB 1219168A GB 1184023 A GB1184023 A GB 1184023A
Authority
GB
United Kingdom
Prior art keywords
radical
formula
substituted
oxazines
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1219168A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CT EUROP DE RECH S MAUVERNAY
Centre Europeen de Recherches Mauvernay CERM
Original Assignee
CT EUROP DE RECH S MAUVERNAY
Centre Europeen de Recherches Mauvernay CERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CT EUROP DE RECH S MAUVERNAY, Centre Europeen de Recherches Mauvernay CERM filed Critical CT EUROP DE RECH S MAUVERNAY
Publication of GB1184023A publication Critical patent/GB1184023A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/12—Saturated ethers containing halogen
    • C07C43/123—Saturated ethers containing halogen both carbon chains are substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

1,184,023. Substituted tetrahydro-1,4-oxazines. CENTRE EUROPEEN DE RECHERCHES MAUVERNAY. 13 March, 1968 [26 June, 1967], No. 12191/68. Heading C2C. The invention comprises novel 2,4- or 2,2,4- substituted tetrahydro - 1,4 - oxazines as described in Tables II and III (not shown) of the Specification, and a process for the production of tetrahydro-1,4-oxazines of the formula where R is a monovalent hydrocarbon radical, which may contain halogen substituents, R<SP>1</SP> is a hydrogen atom or an alkyl radical having up to 6 carbon atoms, and R 1 is hydrogen or an alkenyl radical or a linear, branched or cyclic alkyl radical optionally substituted by a hydroxy radical, alkoxy radical or aryl radical, which may itself be substituted, or a linear or branched alkyl radical substituted by a heterocyclic radical, comprising: (1) adding tertiary butyl hypobromite at a temperature below 0‹ C. to a mixture of glycol chlorohydrin and an olefin of the formula in which R and R<SP>1</SP> are as defined above, to form an intermediate compound of the formula and (2) condensing 1 mole of the said intermediate compound with 3 moles of a primary amine of the formula R 1 -NH 2 in which R 1 is as defined above. Intermediates of the formula where R is phenyl, p-chlorophenyl, methyl or p-fluorobenzyl when R<SP>1</SP> is H, and R is methyl when R<SP>1</SP> is methyl are prepared as in (1) above.
GB1219168A 1967-06-26 1968-03-13 Process for the production of Substituted Tetrahydro-1,4-Oxazines Expired GB1184023A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR111950A FR1535615A (en) 1967-06-26 1967-06-26 Process for obtaining tetrahydro-1, 4-oxazines substituted in 2, 4 and in 2, 2, 4

Publications (1)

Publication Number Publication Date
GB1184023A true GB1184023A (en) 1970-03-11

Family

ID=8633844

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1219168A Expired GB1184023A (en) 1967-06-26 1968-03-13 Process for the production of Substituted Tetrahydro-1,4-Oxazines

Country Status (6)

Country Link
BE (1) BE709011A (en)
CH (1) CH487919A (en)
DE (1) DE1643857A1 (en)
FR (1) FR1535615A (en)
GB (1) GB1184023A (en)
NL (1) NL147728B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0140359A1 (en) * 1983-11-02 1985-05-08 Beecham Group Plc Morpholine derivatives
EP0507863A1 (en) * 1989-12-28 1992-10-14 Virginia Commonwealth University Sigma receptor ligands and the use thereof
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
US6087346A (en) * 1993-06-23 2000-07-11 Cambridge Neuroscience, Inc. Sigma receptor ligands and the use thereof
WO2006077025A2 (en) * 2005-01-18 2006-07-27 F. Hoffmann-La Roche Ag Morpholines as 5ht2c agonists
US7132551B2 (en) 2000-09-11 2006-11-07 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2657476A1 (en) * 1976-12-18 1978-06-22 Basf Ag MORPHOLINE DERIVATIVES
FR2517305B1 (en) * 1981-12-01 1985-10-25 Lafon Labor NOVEL 2-PHENYL-MORPHOLINE DERIVATIVES AND THEIR USE IN THERAPEUTICS
FR2553411B1 (en) * 1983-10-14 1986-08-01 Lafon Labor 2-HALOGENOPHENYL-MORPHOLINE DERIVATIVES, METHOD OF PREPARATION AND THERAPEUTIC USE
FR2553412B1 (en) * 1983-10-17 1986-03-21 Lafon Labor 4-ALKYL-2-METHYL-2-PHENYL-MORPHOLINE DERIVATIVES, METHOD OF PREPARATION AND USE IN THERAPEUTICS

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0140359A1 (en) * 1983-11-02 1985-05-08 Beecham Group Plc Morpholine derivatives
EP0507863A1 (en) * 1989-12-28 1992-10-14 Virginia Commonwealth University Sigma receptor ligands and the use thereof
EP0507863A4 (en) * 1989-12-28 1993-07-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof
US6057371A (en) * 1989-12-28 2000-05-02 Virginia Commonwealth University Sigma receptor ligands and the use thereof
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
US6087346A (en) * 1993-06-23 2000-07-11 Cambridge Neuroscience, Inc. Sigma receptor ligands and the use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
US7132551B2 (en) 2000-09-11 2006-11-07 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof
US7517892B2 (en) 2000-09-11 2009-04-14 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof
US7816375B2 (en) 2000-09-11 2010-10-19 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof
WO2006077025A3 (en) * 2005-01-18 2006-09-08 Hoffmann La Roche Morpholines as 5ht2c agonists
WO2006077025A2 (en) * 2005-01-18 2006-07-27 F. Hoffmann-La Roche Ag Morpholines as 5ht2c agonists
US7323466B2 (en) 2005-01-18 2008-01-29 Hoffman-La Roche Inc. Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity
KR100880997B1 (en) * 2005-01-18 2009-02-03 에프. 호프만-라 로슈 아게 Morpholines as 5ht2c agonists

Also Published As

Publication number Publication date
BE709011A (en) 1968-07-05
NL147728B (en) 1975-11-17
DE1643857A1 (en) 1971-04-15
NL6801287A (en) 1968-12-27
FR1535615A (en) 1968-08-09
CH487919A (en) 1970-03-31

Similar Documents

Publication Publication Date Title
GB1184023A (en) Process for the production of Substituted Tetrahydro-1,4-Oxazines
GB1120463A (en) Derivatives of 1,3-diazafluoranthene-1-oxide
GB1098806A (en) Novel benzoxazinethiones
GB1142309A (en) Improved urea derivatives and their use as herbicides
EP0089765A3 (en) Pyridine derivatives
ES320729A1 (en) Procedure for the synthesis of new derivatives of antranilic acid. (Machine-translation by Google Translate, not legally binding)
SE7415015L (en) METHODS OF PRODUCING NEW 2-PHENYLHYDRAZINO-THIAZOLINES OR -TIAZINES
GB1186495A (en) 0-[3-(4-Fluorobenzoyl) Proplyl]-4-Substituted Piperazines, their Acid Addition Salts and their method of preparation
GB1529903A (en) Piperidine derivatives and their use as stabilisers for synthetic polymers
GB1175775A (en) Novel Amino-Substituted 2-Hydroxyl-3,5-Hydrocarbylbenzyl-3&#39;-Hydrocarbyl-4&#39; Hydroxyphenyl Sulphides and their use as Antioxidants
ES456400A1 (en) Thienothiazine derivatives
GB1237658A (en) Substituted 1-oxy-1-thiono-3-halogen- or -3-alkyl phospholines
DK141282A (en) PROCEDURE FOR MAKING MORPHOLINES
GB1016088A (en) New 7-hydroxychromone derivatives
GB1080880A (en) New thioamides
ES274907A1 (en) Iminodibenzyl derivatives
GB1444967A (en) Pyrocatechol ethers
SE7713779L (en) NEW PHENYL DERIVATIVES
GB1490060A (en) 2-(3-substituted-4h-1,2,4-triazol-4-yl)benzo-phenones
KR920007971A (en) Benzoquinone compounds
ES446566A1 (en) A procedure for the preparation of derivatives of 1-amino- (replaced) -3-4&#39;-0-5&#39;-tiazol (replaced) -2-oxi-2-propanol. (Machine-translation by Google Translate, not legally binding)
GB1007587A (en) Thiazine dione derivatives and the preparation thereof
ES316532A1 (en) Procedure for the obtaining of new seudo-indoles replaced basically. (Machine-translation by Google Translate, not legally binding)
ES301516A1 (en) Procedure for the preparation of tricyclic amines (Machine-translation by Google Translate, not legally binding)
ES267692A3 (en) Procedure for the obtaining of amidas of fatty acids 0,0-dialquil-ditiofosforºlicos (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
PS Patent sealed
435 Patent endorsed 'licences of right' on the date specified (sect. 35/1949)
PCNP Patent ceased through non-payment of renewal fee